As of 30 Sep 2025, 321 institutional investors reported holding 85,200,989 shares of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 491,802 | $7,679,182 | -$291,946 | $15.59 | 25 |
| 2025 Q3 | 85,200,989 | $1,247,351,823 | +$106,200,543 | $14.64 | 321 |
| 2025 Q2 | 77,806,551 | $1,202,786,823 | +$106,862,939 | $15.46 | 308 |
| 2025 Q1 | 71,086,297 | $1,057,032,461 | -$156,051 | $14.87 | 299 |
| 2024 Q4 | 72,012,903 | $953,504,824 | -$55,385,495 | $13.24 | 291 |
| 2024 Q3 | 71,553,169 | $1,015,380,211 | +$20,522,204 | $14.22 | 296 |
| 2024 Q2 | 72,061,993 | $940,730,763 | -$86,515,524 | $12.94 | 282 |
| 2024 Q1 | 78,179,295 | $1,087,229,372 | -$75,255,783 | $13.89 | 310 |
| 2023 Q4 | 83,203,742 | $1,187,331,253 | +$44,580,205 | $14.27 | 298 |
| 2023 Q3 | 80,186,873 | $1,238,629,561 | -$62,722,531 | $15.47 | 305 |
| 2023 Q2 | 83,777,518 | $1,316,226,289 | -$49,940,581 | $15.71 | 302 |
| 2023 Q1 | 81,595,481 | $1,344,608,359 | +$254,847,296 | $16.48 | 288 |
| 2022 Q4 | 67,666,668 | $1,057,415,212 | +$60,430,987 | $15.60 | 270 |
| 2022 Q3 | 63,286,946 | $821,024,064 | +$94,369,882 | $12.97 | 250 |
| 2022 Q2 | 56,642,643 | $795,035,114 | +$69,132,475 | $14.04 | 251 |
| 2022 Q1 | 55,744,115 | $796,890,075 | -$259,336,061 | $14.32 | 257 |
| 2021 Q4 | 71,118,095 | $970,947,825 | -$282,516,518 | $13.63 | 262 |
| 2021 Q3 | 91,724,629 | $1,500,956,919 | -$41,562,730 | $16.38 | 269 |
| 2021 Q2 | 94,721,080 | $1,594,590,144 | -$223,728,219 | $16.83 | 281 |
| 2021 Q1 | 107,236,456 | $1,956,547,194 | -$5,542,824 | $18.26 | 294 |
| 2020 Q4 | 108,387,616 | $1,971,794,573 | +$47,702,291 | $18.20 | 283 |
| 2020 Q3 | 107,376,034 | $1,906,201,737 | -$77,868,691 | $17.84 | 290 |
| 2020 Q2 | 110,211,131 | $1,975,638,827 | -$82,796,616 | $17.93 | 284 |
| 2020 Q1 | 115,444,746 | $1,753,768,853 | -$255,755,250 | $15.18 | 279 |
| 2019 Q4 | 129,205,921 | $2,550,743,065 | -$263,240,299 | $19.73 | 315 |
| 2019 Q3 | 141,442,566 | $2,431,872,070 | -$10,065,934 | $17.20 | 287 |
| 2019 Q2 | 144,946,940 | $2,566,665,939 | -$492,403,542 | $17.70 | 318 |
| 2019 Q1 | 177,136,508 | $3,606,435,287 | +$2,478,311,203 | $20.37 | 357 |
| 2018 Q4 | 53,758,263 | $907,732,778 | +$834,155,233 | $16.82 | 79 |
| 2018 Q3 | 2,915,346 | $62,314,000 | +$9,170,362 | $21.37 | 14 |
| 2018 Q2 | 2,486,238 | $52,071,000 | +$10,805,823 | $20.90 | 12 |
| 2018 Q1 | 1,884,207 | $45,983,000 | +$5,617,797 | $24.55 | 8 |
| 2017 Q4 | 1,652,653 | $47,012,000 | +$7,825,828 | $28.30 | 7 |
| 2017 Q3 | 1,377,452 | $38,131,326 | +$9,513,045 | $27.54 | 6 |
| 2017 Q2 | 1,032,922 | $26,255,135 | +$3,289,775 | $25.42 | 5 |
| 2017 Q1 | 903,509 | $21,336,985 | +$7,304,729 | $23.63 | 5 |
| 2016 Q4 | 598,154 | $12,427,746 | +$279,511 | $20.78 | 6 |
| 2016 Q3 | 583,858 | $13,971,000 | +$3,234,562 | $23.88 | 4 |
| 2016 Q2 | 449,504 | $9,682,809 | -$5,836,092 | $21.54 | 6 |
| 2016 Q1 | 720,508 | $16,443,917 | +$3,726,373 | $22.82 | 7 |
| 2015 Q4 | 557,111 | $13,958,103 | +$8,511,509 | $25.02 | 8 |
| 2015 Q3 | 231,689 | $5,064,000 | -$7,911,833 | $21.88 | 8 |
| 2015 Q2 | 556,323 | $13,465,000 | +$636,076 | $24.16 | 7 |
| 2015 Q1 | 529,554 | $13,251,000 | +$1,844,506 | $25.00 | 8 |
| 2014 Q4 | 455,916 | $9,476,000 | -$83,573 | $20.84 | 8 |
| 2014 Q3 | 459,996 | $10,000,000 | +$530,655 | $21.75 | 8 |
| 2014 Q2 | 435,563 | $10,116,000 | -$6,899,908 | $23.19 | 7 |
| 2014 Q1 | 726,088 | $17,232,000 | +$5,027,584 | $23.75 | 9 |